Innate Pharma Organise une Conférence Téléphonique et un Webcast pour ses Résultats Financiers au Premier Semestre 2021
September 07, 2021 01:00 ET
|
INNATE PHARMA
Marseille, France, 07 sept. 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») a annoncé aujourd'hui qu'elle organise une conférence...
Innate Pharma Announces Conference Call and Webcast for First Half 2021 Business Update
September 07, 2021 01:00 ET
|
INNATE PHARMA
Marseille, France, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call...
Innate Pharma Announces Conference Call and Webcast for First Half 2021 Business Update
September 07, 2021 01:00 ET
|
INNATE PHARMA
MARSEILLE, France, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call...
Monalizumab and ANKET™ Data Will Be Presented at ESMO 2021 Virtual Congress
September 02, 2021 02:00 ET
|
INNATE PHARMA
MARSEILLE, France, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that two oral presentations will be highlighted...
Des données sur monalizumab et ANKET™ seront présentées au congrès virtuel de l’ESMO 2021
September 02, 2021 02:00 ET
|
INNATE PHARMA
Marseille, France, 02 sept. 2021 (GLOBE NEWSWIRE) -- De nouvelles données sur monalizumab en combinaison avec durvalumab seront présentée par AstraZeneca dans le cadre d’un “late-breaking abstract”...
Monalizumab and ANKET™ Data Will be Presented at ESMO 2021 Virtual Congress
September 02, 2021 02:00 ET
|
INNATE PHARMA
Marseille, France, Sept. 02, 2021 (GLOBE NEWSWIRE) -- AstraZeneca to present new data on monalizumab in combination with durvalumab in a late-breaking abstract on COAST Phase 2 trial Innate Pharma...
Prochains Rendez-Vous Investisseurs d'Innate Pharma
August 30, 2021 01:00 ET
|
INNATE PHARMA
Marseille, France, 30 août 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris : IPH – ISIN: FR0010331421 ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce aujourd’hui que des...
Innate Pharma to Participate in Upcoming Investor Conferences
August 30, 2021 01:00 ET
|
INNATE PHARMA
Marseille, France, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its senior...
Innate Pharma to Participate in Upcoming Investor Conferences
August 30, 2021 01:00 ET
|
INNATE PHARMA
MARSEILLE, France, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its senior...
Number of Shares and Voting Rights of Innate Pharma as of August 1, 2021
August 11, 2021 01:00 ET
|
INNATE PHARMA
Marseille, France, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities (Autorité des...